During the past decade, Orlando Clinical Research Center conducted 164 clinical trials. In the 10-year time frame, 164 clinical trials started and 57 clinical trials were completed, i.e. on average, 34.8% percent of trials that started reached the finish line to date. In the past 5 years, 82 clinical trials started and 39 clinical trials were completed. i.e. 47.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Orlando Clinical Research Center" #1 sponsor was "Bristol-Myers Squibb" with 22 trials, followed by "Eli Lilly and Company" with 13 trials sponsored, "Gilead Sciences" with 13 trials sponsored, "Pfizer" with 13 trials sponsored and "Novartis Pharmaceuticals" with 13 trials sponsored. Other sponsors include 160 different institutions and companies that sponsored additional 97 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Orlando Clinical Research Center" #1 collaborator was "Celerion" with 3 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator, "Covance" with 2 trials as a collaborator, "Loxo Oncology, Inc." with 2 trials as a collaborator and "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Orlando Clinical Research Center" are "Hepatic Impairment" (60 trials), "Renal Impairment" (31 trials), "Healthy" (15 trials), "Renal Insufficiency" (14 trials) and "End Stage Renal Disease" (12 trials). Many other conditions were trialed in "Orlando Clinical Research Center" in a lesser frequency.

Most popular intervention types in "Orlando Clinical Research Center" are "Drug" (225 trials), "Biological" (9 trials), "Device" (3 trials), "Other" (3 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (22 trials), "BMS-986177" (4 trials), "Triferic" (4 trials), "placebo" (4 trials) and "Daclatasvir" (3 trials). Other intervention names were less common.

The vast majority of trials in "Orlando Clinical Research Center" are 226 trials for "All" genders, 7 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Orlando Clinical Research Center". undefined are not yet recruiting, 16 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 204 completed trials in Orlando Clinical Research Center, 1 suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Orlando Clinical Research Center, 195 "Phase 1" clinical trials were conducted, 27 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 2 trials that are defined as “Not Applicable".